Literature DB >> 15733564

Heteropoda toxin 2 is a gating modifier toxin specific for voltage-gated K+ channels of the Kv4 family.

Vladislav V Zarayskiy1, Ganesh Balasubramanian, Vladimir E Bondarenko, Michael J Morales.   

Abstract

Kv4 voltage-gated K(+) channels are responsible for transient K(+) currents in the central nervous system and in the heart. HpTx2 is a peptide toxin that selectively inhibits these currents; making it a useful probe for understanding Kv4 channel structure and drug binding. Therefore, we developed a method to produce large amounts of recombinant HpTx2. Recombinant toxin inhibits all three Kv4 isoforms to the same degree; however, the voltage-dependence of inhibition is less apparent for Kv4.1 than for Kv4.3. Similarly, recombinant HpTx2(GS) effects gating characteristics of both channels, but Kv4.1 to a much lesser degree. The toxin lacks affinity for Kv1.4, Kv2.1, and Kv3.4. To locate the binding site, the amino acids linking the third and forth membrane spanning segments of Kv4.3 were replaced with analogous amino acids of Kv1.4. The chimeric K(+) channel was completely insensitive to block by rHpTx2, suggesting that its binding site is near the channel's voltage sensor. These data show that rHpTx2(GS) is a gating modifier toxin that binds to a site remote from the pore.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15733564     DOI: 10.1016/j.toxicon.2004.11.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  23 in total

1.  Effect of the I(to) activator NS5806 on cloned K(V)4 channels depends on the accessory protein KChIP2.

Authors:  A Lundby; T Jespersen; N Schmitt; M Grunnet; S-P Olesen; J M Cordeiro; K Calloe
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Manipulating Kv4.2 identifies a specific component of hippocampal pyramidal neuron A-current that depends upon Kv4.2 expression.

Authors:  Aaron Lauver; Li-Lian Yuan; Andreas Jeromin; Brian M Nadin; José J Rodríguez; Heather A Davies; Michael G Stewart; Gang-Yi Wu; Paul J Pfaffinger
Journal:  J Neurochem       Date:  2006-10-05       Impact factor: 5.372

Review 3.  Tarantula toxins interacting with voltage sensors in potassium channels.

Authors:  Kenton J Swartz
Journal:  Toxicon       Date:  2006-09-29       Impact factor: 3.033

4.  Neurokinins enhance excitability in capsaicin-responsive DRG neurons.

Authors:  Adrian Sculptoreanu; William C de Groat
Journal:  Exp Neurol       Date:  2007-02-14       Impact factor: 5.330

5.  S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3.

Authors:  Christopher V DeSimone; YiChun Lu; Vladimir E Bondarenko; Michael J Morales
Journal:  Mol Pharmacol       Date:  2009-04-08       Impact factor: 4.436

Review 6.  Computational methods of studying the binding of toxins from venomous animals to biological ion channels: theory and applications.

Authors:  Dan Gordon; Rong Chen; Shin-Ho Chung
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

7.  Inhibition of A-type potassium current by the peptide toxin SNX-482.

Authors:  Tilia Kimm; Bruce P Bean
Journal:  J Neurosci       Date:  2014-07-09       Impact factor: 6.167

8.  Is lipid bilayer binding a common property of inhibitor cysteine knot ion-channel blockers?

Authors:  Yevgen O Posokhov; Philip A Gottlieb; Michael J Morales; Frederick Sachs; Alexey S Ladokhin
Journal:  Biophys J       Date:  2007-06-15       Impact factor: 4.033

9.  Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics.

Authors:  Andrew J Shepherd; Lipin Loo; Raeesa P Gupte; Aaron D Mickle; Durga P Mohapatra
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

10.  Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets.

Authors:  Reshma Ramracheya; Caroline Ward; Makoto Shigeto; Jonathan N Walker; Stefan Amisten; Quan Zhang; Paul R Johnson; Patrik Rorsman; Matthias Braun
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.